AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Wednesday's Doom Tour: A Global Marketing Campaign
ByAinvest
Monday, Sep 15, 2025 9:47 am ET1min read
Wednesday's cast and creative team embarked on a 2-month "Doom Tour" visiting 16 cities across five continents, garnering over 200,000 followers. The Season 2 marketing campaign amassed over 9B owned social impressions, surpassing Season 1 and becoming one of Netflix's most talkable social campaigns. Fans embraced the campaign, with limited-edition Cheetos products becoming top sellers. The series topped the Global Top 10 TV List with 28.2M views following the debut of Part 2.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet